[
    [
        {
            "time": "2019-02-07",
            "original_text": "沃森生物2019年净利同比降86%",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利润",
                    "同比下降",
                    "86%"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物2019年净利同比降86%",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "沃森生物2018年实现净利1.45亿 同比下降86.14% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利",
                    "同比下降",
                    "86.14%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物2018年实现净利1.45亿 同比下降86.14% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "沃森生物：2019年净利润同比减86.14%（业绩快报） 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利润",
                    "同比减少",
                    "86.14%",
                    "业绩快报",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：2019年净利润同比减86.14%（业绩快报） 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "沃森生物业绩快报：2019年净利同比降86% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "业绩快报",
                    "净利",
                    "同比下降",
                    "86%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物业绩快报：2019年净利同比降86% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "沃森生物：2019实现净利1.45亿元 同比下降86.14% 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利",
                    "同比下降",
                    "86.14%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：2019实现净利1.45亿元 同比下降86.14% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "沃森生物(300142.SZ)披露业绩快报2019年度净利润降86.14%至1.45亿元 盈利能力下降",
            "features": {
                "keywords": [
                    "沃森生物",
                    "业绩快报",
                    "净利润",
                    "同比下降",
                    "86.14%",
                    "1.45亿元",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)披露业绩快报2019年度净利润降86.14%至1.45亿元 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]